Skip to main content
Premium Trial:

Request an Annual Quote

Organon Renews, Expands Subscription Deal with Lexicon

NEW YORK, July 26 - Dutch pharmaceutical company Organon had agreed to renew and expand its subscription to Lexicon’s OmniBank library and DNA sequence database, Lexicon Genetics said Thursday.

Under the terms of the deal, Oragnon will have access to Lexicon’s tools through December 2002. In addition, Organon will also have access to Lexicon’s gene knockouts as well as to drug target validation data generated by Lexicon for specified targets.

In exchange, Organon will pay annual technology access fees and research funding of an undisclosed amount.

"We believe that Organon's decision to expand its target validation agreement with us is indicative of the value our partners receive by tapping Lexicon's technology and expertise to discover the in vivo functions of genes," Arthur Sands, CEO of Lexicon, said in a statement.

Driek Vergouwen, managing director of research and development at Organon, said that the deal would provide the company with valuable information about gene function.

"Lexicon's expertise in analyzing key mammalian phenotypic characteristics in gene knockouts will enable Organon to learn more about the functions of genes for the benefit of our drug discovery programs that focus on major human diseases," Vergouwen said.

Lexicon Genetics of The Woodlands, Texas, uses gene knockout technology to determine the functions of genes.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.